| Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation JT Thaiparambil, L Bender, T Ganesh, E Kline, P Patel, Y Liu, ... International journal of cancer 129 (11), 2744-2755, 2011 | 292 | 2011 |
| Cyclooxygenase‐2 in epilepsy A Rojas, J Jiang, T Ganesh, MS Yang, N Lelutiu, P Gueorguieva, ... Epilepsia 55 (1), 17-25, 2014 | 195 | 2014 |
| Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation J Jiang, Y Quan, T Ganesh, WA Pouliot, FE Dudek, R Dingledine Proceedings of the National Academy of Sciences 110 (9), 3591-3596, 2013 | 171 | 2013 |
| The bioactive Taxol conformation on β-tubulin: Experimental evidence from highly active constrained analogs T Ganesh, RC Guza, S Bane, R Ravindra, N Shanker, AS Lakdawala, ... Proceedings of the National Academy of Sciences 101 (27), 10006-10011, 2004 | 140 | 2004 |
| Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases Y Chang, T Ganesh, JR Horton, A Spannhoff, J Liu, A Sun, X Zhang, ... Journal of molecular biology 400 (1), 1-7, 2010 | 131 | 2010 |
| Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2 J Jiang, T Ganesh, Y Du, Y Quan, G Serrano, M Qui, I Speigel, A Rojas, ... Proceedings of the National Academy of Sciences 109 (8), 3149-3154, 2012 | 126 | 2012 |
| Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits SME Smith, J Min, T Ganesh, B Diebold, T Kawahara, Y Zhu, J McCoy, ... Chemistry & biology 19 (6), 752-763, 2012 | 125 | 2012 |
| Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus J Jiang, M Yang, Y Quan, P Gueorguieva, T Ganesh, R Dingledine Neurobiology of disease 76, 126-136, 2015 | 105 | 2015 |
| Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury CL Eastman, R D'Ambrosio, T Ganesh Neuropharmacology 172, 107907, 2020 | 94 | 2020 |
| Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor J Jiang, T Ganesh, Y Du, P Thepchatri, A Rojas, I Lewis, S Kurtkaya, L Li, ... Proceedings of the National Academy of Sciences 107 (5), 2307-2312, 2010 | 94 | 2010 |
| Asymmetric synthesis of the putative structure of (−)-oryzoxymycin ME Bunnage, T Ganesh, IB Masesane, D Orton, PG Steel Organic Letters 5 (3), 239-242, 2003 | 88 | 2003 |
| Prostanoid receptor EP2 as a therapeutic target: Miniperspective T Ganesh Journal of medicinal chemistry 57 (11), 4454-4465, 2014 | 85 | 2014 |
| Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3 ‘bridged paclitaxel analogues T Ganesh, C Yang, A Norris, T Glass, S Bane, R Ravindra, A Banerjee, ... Journal of medicinal chemistry 50 (4), 713-725, 2007 | 85 | 2007 |
| Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus A Rojas, T Ganesh, N Lelutiu, P Gueorguieva, R Dingledine Neuropharmacology 93, 15-27, 2015 | 82 | 2015 |
| Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects H Yuan, SJ Myers, G Wells, KL Nicholson, SA Swanger, P Lyuboslavsky, ... Neuron 85 (6), 1305-1318, 2015 | 81 | 2015 |
| Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats A Rojas, T Ganesh, Z Manji, T O'neill, R Dingledine Neuropharmacology 110, 419-430, 2016 | 76 | 2016 |
| High-throughput assays for superoxide and hydrogen peroxide: design of a screening workflow to identify inhibitors of NADPH oxidases J Zielonka, G Cheng, M Zielonka, T Ganesh, A Sun, J Joseph, R Michalski, ... Journal of Biological Chemistry 289 (23), 16176-16189, 2014 | 75 | 2014 |
| Improved biochemical strategies for targeted delivery of taxoids T Ganesh Bioorganic & medicinal chemistry 15 (11), 3597-3623, 2007 | 74 | 2007 |
| Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells E Curry, I Green, N Chapman-Rothe, E Shamsaei, S Kandil, FL Cherblanc, ... Clinical epigenetics 7, 1-12, 2015 | 72 | 2015 |
| Diels–alder approach to tetralin-based constrained α-amino acid derivatives S Kotha, T Ganesh, AK Ghosh Bioorganic & medicinal chemistry letters 10 (15), 1755-1757, 2000 | 64 | 2000 |
